Stevanato Group S.p.A (STVN) Enterprise Value (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Enterprise Value of -$142.9 million for Q1 2026, down 39.95% year-over-year from -$238.0 million in Q1 2025, and up 13.14% quarter-over-quarter from -$164.5 million in Q4 2025.
Stevanato Group S.p.A (STVN) Enterprise Value (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Enterprise Value for 7 consecutive years, with -$142.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 39.95% year-over-year to -$142.9 million; the TTM figure through Mar 2026 stood at -$142.9 million (down 39.95% YoY), while the FY2025 annual figure was -$164.5 million, down 54.66% from the prior year.
- Enterprise Value improved to -$142.9 million in Q1 2026 per STVN's latest filing, from -$164.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$72.4 million in Q2 2023 and bottomed at -$444.1 million in Q1 2022.
- Historically, Enterprise Value has averaged -$173.7 million across 5 years, with a median of -$141.5 million in 2025.
- Annual changes were most pronounced in 2022 — Enterprise Value slumped 1150628.62% — and 2023, when it surged 80.39%.
- Stevanato Group S.p.A's Enterprise Value stood at -$267.9 million in 2022, then surged by 70.32% to -$79.5 million in 2023, then slumped by 33.82% to -$106.4 million in 2024, then tumbled by 54.66% to -$164.5 million in 2025, then grew by 13.14% to -$142.9 million in 2026.
- Business Quant data shows STVN's Enterprise Value at -$142.9 million in Q1 2026, -$164.5 million in Q4 2025, and -$141.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.83 Bn | 129.61 Bn | 1.96 Bn | -5.09 Bn |
| 2 | Becton Dickinson | 52.55 Bn | 51.69 Bn | 2.32 Bn | -863.00 Mn |
| 3 | Alcon | 35.76 Bn | 34.41 Bn | 1.68 Bn | -1.36 Bn |
| 4 | Resmed | 33.94 Bn | 32.47 Bn | 861.22 Mn | -1.47 Bn |
| 5 | Medline | 29.10 Bn | 26.42 Bn | 2.22 Bn | 4.83 Bn |
| 6 | West Pharmaceutical Services | 24.93 Bn | 24.50 Bn | 329.20 Mn | -435.80 Mn |
| 7 | Solventum | 15.39 Bn | 14.99 Bn | 1.29 Bn | -403.00 Mn |
| 8 | Cooper Companies | 14.84 Bn | 14.70 Bn | 735.40 Mn | -138.60 Mn |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn | -2.18 Bn |
| 10 | Stevanato Group S.p.A | 6.13 Bn | 6.03 Bn | 100.91 Mn | -107.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -107.98 Mn |
| Mar 31, 2026 | -142.91 Mn |
| Dec 31, 2025 | -164.53 Mn |
| Sep 30, 2025 | -141.52 Mn |
| Jun 30, 2025 | -120.71 Mn |
| Mar 31, 2025 | -102.12 Mn |
| Dec 31, 2024 | -106.38 Mn |
| Sep 30, 2024 | -88.51 Mn |
| Jun 30, 2024 | -86.60 Mn |
| Mar 31, 2024 | -205.98 Mn |
| Dec 31, 2023 | -79.50 Mn |
| Sep 30, 2023 | -73.06 Mn |
| Jun 30, 2023 | -72.41 Mn |
| Mar 31, 2023 | -192.14 Mn |
| Dec 31, 2022 | -267.88 Mn |
| Sep 30, 2022 | -295.96 Mn |
| Jun 30, 2022 | -369.22 Mn |
| Mar 31, 2022 | -444.10 Mn |
| Dec 31, 2021 | -501.81 Mn |
| Sep 30, 2021 | -537.45 Mn |